BLS — BLS Pharmaceuticals Share News
0.000.00%
- AU$255.28m
- AU$250.42m
- AU$74.23m
Australia Stock Exchange release from BIOXYNE : Appendix 4C - quarterly
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:56:43
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 15:55:42
Australia Stock Exchange release from BIOXYNE : Response to ASX Price Query
Australia Stock Exchange release from BIOXYNE : Appendix 4D and Half Year Accounts
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 12:29:03
Australia Stock Exchange release from BIOXYNE : Appendix 4C - Quarterly December 2020
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:04:24
Australia Stock Exchange release from BIOXYNE : Results of Meeting
Australia Stock Exchange release from BIOXYNE : Appendix 4C - quarterly
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 10:52:06
Australia Stock Exchange release from BIOXYNE : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from BIOXYNE : Appendix 4G and Corporate Governance
Australia Stock Exchange release from BIOXYNE : Annual Report to shareholders
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 08:42:49
Australia Stock Exchange release from BIOXYNE : Preliminary Final Report
Australia Stock Exchange release from BIOXYNE : Response to ASX Price Query
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:25:52
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:14:37